Earnings Feed
Start Free
Regulus Therapeutics Inc.·4

Feb 7, 5:09 PM ET

Drygin Denis 4

4 · Regulus Therapeutics Inc. · Filed Feb 7, 2022

Insider Transaction Report

Form 4
Period: 2022-02-04
Regulus Therapeutics Inc.RGLS
Drygin Denis
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2022-02-04$0.23/sh+23,314$5,362→ 23,314 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION